CymaBay Therapeutics, Inc. Made Big Gain
Fri, Jun 30, 2023 at 07:58 PM
CymaBay Therapeutics, Inc. (CBAY:NASDAQ) jumped higher at $10.95, a gain of 39.7%. On Fri, Jun 30, 2023, CBAY:NASDAQ hit a New 2-Week High of $10.95. The stock got featured on our News Catalysts scanner on Fri, Jun 30, 2023 at 01:45 PM in the 'MISCELLANEOUS' category. From Fri, Jun 16, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
About CymaBay Therapeutics, Inc. (CBAY:NASDAQ)
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%